Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
The British Journal of Dermatology|November 25, 2017
The association between atopic dermatitis and hand eczema: a systematic review and meta-analysisS M D Ruff, K A Engebretsen, C Zachariae, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 30, 2018
Atopic dermatitis and alcohol use - a meta-analysis and systematic reviewA-S Halling-Overgaard, C R Hamann, R P Holm, et al.The British Journal of Dermatology|May 10, 2017
Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitisR Chopra, P P Vakharia, R Sacotte, et al.Allergy|September 15, 2017
Validation of patient-reported global severity of atopic dermatitis in adultsP P Vakharia, R Chopra, R Sacotte, et al.The British Journal of Dermatology|September 7, 2020
Characteristics and impacts of itch in children with inflammatory skin disordersM M Fang, C J Nowinski, J Lai, et al.The British Journal of Dermatology|October 5, 2021
Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitisJ Puelles, F Fofana, D Rodriguez, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 24, 2022
High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescentsS Ständer, N Bhatia, M J Gooderham, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2019
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statementY A Leshem, R Bissonnette, C Paul, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 25, 2023
Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in patient-reported symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trialsK Reich, M S de Bruin-Weller, M Deleuran, et al.The British Journal of Dermatology|April 12, 2019
Validation of five patient-reported outcomes for atopic dermatitis severity in adultsJ I Silverberg, D J Margolis, M Boguniewicz, et al.Pageof 7